CEO.CA's Inside the Boardroom: Major U.S. Cancer Centers Are Testing This New Drug: Kairos Pharma

Kairos Pharma (NYSE American: KAPA) was featured in a CEO.CA 'Inside the Boardroom' video interview in which CEO & Chairman Dr. John S. Yu discusses positive efficacy data for its lead cancer drug and ongoing trial enrollment. The release is a promotional media placement issued on behalf of Kairos by CEO.CA (an EarthLabs subsidiary); it contains no new clinical data, financial figures, or regulatory milestones.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.